A metabolikus PET-vizsgálatok helye a kardiológiai képalkotó eljárások között.

Translated title of the contribution: The role of PET scan among cardiologic imaging methods

Zsolt Köszegi, L. Galuska, S. Szakáll, Szabolcs Lehel, Tibor Fülöp, I. Édes, L. Balkay

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The PET technique has been available for myocardial viability studies in Hungary since 1994. The early comparative results showed that FDG-PET identified more potentially reversible myocardial damages than [201Tl]-scintigraphy, defining the viability either by preserved metabolic activity of 50% or by metabolism-perfusion mismatch. According to the follow up of revascularized patients in our cases, FDG-PET had a positive predictive value for functional recovery at 80%. In our opinion, it is the detection of glucose metabolism that predicts with the greatest accuracy segments of hibernating myocardial tissue that will recover after revascularization. Unlike dobutamine echocardiography, PET can detect viable ventricular segments in the myocardium of lost contractile material often seen in the histological studies of chronically ischemic myocardium. The FDG-PET method can be regarded as the gold standard of myocardial viability.

Original languageHungarian
Pages (from-to)1314-1316
Number of pages3
JournalOrvosi Hetilap
Volume143
Issue number21 Suppl 3
Publication statusPublished - May 26 2002

Fingerprint

Positron-Emission Tomography
Myocardium
Dobutamine
Hungary
Radionuclide Imaging
Echocardiography
Perfusion
Glucose

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A metabolikus PET-vizsgálatok helye a kardiológiai képalkotó eljárások között. / Köszegi, Zsolt; Galuska, L.; Szakáll, S.; Lehel, Szabolcs; Fülöp, Tibor; Édes, I.; Balkay, L.

In: Orvosi Hetilap, Vol. 143, No. 21 Suppl 3, 26.05.2002, p. 1314-1316.

Research output: Contribution to journalArticle

Köszegi, Zsolt ; Galuska, L. ; Szakáll, S. ; Lehel, Szabolcs ; Fülöp, Tibor ; Édes, I. ; Balkay, L. / A metabolikus PET-vizsgálatok helye a kardiológiai képalkotó eljárások között. In: Orvosi Hetilap. 2002 ; Vol. 143, No. 21 Suppl 3. pp. 1314-1316.
@article{f4b249e4a03a485d90235dbbc11556b1,
title = "A metabolikus PET-vizsg{\'a}latok helye a kardiol{\'o}giai k{\'e}palkot{\'o} elj{\'a}r{\'a}sok k{\"o}z{\"o}tt.",
abstract = "The PET technique has been available for myocardial viability studies in Hungary since 1994. The early comparative results showed that FDG-PET identified more potentially reversible myocardial damages than [201Tl]-scintigraphy, defining the viability either by preserved metabolic activity of 50{\%} or by metabolism-perfusion mismatch. According to the follow up of revascularized patients in our cases, FDG-PET had a positive predictive value for functional recovery at 80{\%}. In our opinion, it is the detection of glucose metabolism that predicts with the greatest accuracy segments of hibernating myocardial tissue that will recover after revascularization. Unlike dobutamine echocardiography, PET can detect viable ventricular segments in the myocardium of lost contractile material often seen in the histological studies of chronically ischemic myocardium. The FDG-PET method can be regarded as the gold standard of myocardial viability.",
author = "Zsolt K{\"o}szegi and L. Galuska and S. Szak{\'a}ll and Szabolcs Lehel and Tibor F{\"u}l{\"o}p and I. {\'E}des and L. Balkay",
year = "2002",
month = "5",
day = "26",
language = "Hungarian",
volume = "143",
pages = "1314--1316",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "21 Suppl 3",

}

TY - JOUR

T1 - A metabolikus PET-vizsgálatok helye a kardiológiai képalkotó eljárások között.

AU - Köszegi, Zsolt

AU - Galuska, L.

AU - Szakáll, S.

AU - Lehel, Szabolcs

AU - Fülöp, Tibor

AU - Édes, I.

AU - Balkay, L.

PY - 2002/5/26

Y1 - 2002/5/26

N2 - The PET technique has been available for myocardial viability studies in Hungary since 1994. The early comparative results showed that FDG-PET identified more potentially reversible myocardial damages than [201Tl]-scintigraphy, defining the viability either by preserved metabolic activity of 50% or by metabolism-perfusion mismatch. According to the follow up of revascularized patients in our cases, FDG-PET had a positive predictive value for functional recovery at 80%. In our opinion, it is the detection of glucose metabolism that predicts with the greatest accuracy segments of hibernating myocardial tissue that will recover after revascularization. Unlike dobutamine echocardiography, PET can detect viable ventricular segments in the myocardium of lost contractile material often seen in the histological studies of chronically ischemic myocardium. The FDG-PET method can be regarded as the gold standard of myocardial viability.

AB - The PET technique has been available for myocardial viability studies in Hungary since 1994. The early comparative results showed that FDG-PET identified more potentially reversible myocardial damages than [201Tl]-scintigraphy, defining the viability either by preserved metabolic activity of 50% or by metabolism-perfusion mismatch. According to the follow up of revascularized patients in our cases, FDG-PET had a positive predictive value for functional recovery at 80%. In our opinion, it is the detection of glucose metabolism that predicts with the greatest accuracy segments of hibernating myocardial tissue that will recover after revascularization. Unlike dobutamine echocardiography, PET can detect viable ventricular segments in the myocardium of lost contractile material often seen in the histological studies of chronically ischemic myocardium. The FDG-PET method can be regarded as the gold standard of myocardial viability.

UR - http://www.scopus.com/inward/record.url?scp=0037177960&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037177960&partnerID=8YFLogxK

M3 - Article

VL - 143

SP - 1314

EP - 1316

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 21 Suppl 3

ER -